News
The double ring, spool-like structure of RAD52 protects replicating DNA in dividing cells. A study led by the University of ...
RAD52 has already shown promise as a drug target. Inhibitors of the protein can selectively kill cancerous cells while ...
A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and protects replicating DNA in dividing cells. This new structural and ...
A University of Iowa-led study has revealed the unexpected structure adopted by the DNA repair protein RAD52 as it binds and ...
In the phase 3 PROpel trial (NCT03732820) patients with metastatic castration-resistant prostate cancer (mCRPC) treated with olaparib plus abiraterone in the first-line setting showed significantly ...
Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A first-line regimen involving pembrolizumab (Keytruda) and olaparib (Lynparza) significantly reduced the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results